Faze Medicines, Inc.
Biotechnology company · Cambridge, Massachusetts, United States
Faze Medicines, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2018. It has reported private securities offerings to the US SEC, most recently $30 million sold in a notice filed in 2020.
Faze Medicines at a glance
What does Faze Medicines do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $30.4 million sold (2020).
Frequently asked questions about Faze Medicines
Where is Faze Medicines headquartered?
Faze Medicines, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Faze Medicines do?
Faze Medicines, Inc. is a biotechnology company.
When was Faze Medicines founded?
The earliest incorporation on record for Faze Medicines, Inc. is in 2018, according to public company registers.
Similar companies
- Editas Medicine, Inc.Cambridge, Massachusetts, United States
- Moderna, Inc.Cambridge, Massachusetts, United States
- Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
- Beam Therapeutics Inc.Cambridge, Massachusetts, United States
- Genzyme CorpCambridge, Massachusetts, United States
- Neutrolis Inc.Cambridge, Massachusetts, United States
- Biogen Inc.Cambridge, Massachusetts, United States
- Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences